1525 O'Brien Drive
About GRAIL, Inc.
GRAIL is a diagnostic company that will develop a pan-cancer screening test by directly measuring circulating nucleic acids in blood
CEO: Jeff Huber
Please click here for Grail job opportunities.
53 articles with GRAIL, Inc.
Backed by Amazon and Big Names Like Bristol-Myers Squibb, Celgene and Merck & Co., Bay Area's GRAIL Banks $900 Million
Bristol-Myers Squibb Release: Investment And Planned Collaboration With GRAIL On Blood-Based Cancer Screening
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
GRAIL Announces Circulating Cell-free Genome Atlas (CCGA) Study As Foundation For Development Of Blood Test To Detect Cancer Early